These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10419556)

  • 21. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol.
    Tesmer JJ; Tesmer VM; Lodowski DT; Steinhagen H; Huber J
    J Med Chem; 2010 Feb; 53(4):1867-70. PubMed ID: 20128603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding.
    Frantz B; Klatt T; Pang M; Parsons J; Rolando A; Williams H; Tocci MJ; O'Keefe SJ; O'Neill EA
    Biochemistry; 1998 Sep; 37(39):13846-53. PubMed ID: 9753474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the T-type Ca2+ current by the dopamine D1 receptor in rat adrenal glomerulosa cells: requirement of the combined action of the G betagamma protein subunit and cyclic adenosine 3',5'-monophosphate.
    Drolet P; Bilodeau L; Chorvatova A; Laflamme L; Gallo-Payet N; Payet MD
    Mol Endocrinol; 1997 Apr; 11(4):503-14. PubMed ID: 9092802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel molecular probes of the Rio1 atypical protein kinase.
    Mielecki M; Krawiec K; Kiburu I; Grzelak K; Zagórski W; Kierdaszuk B; Kowa K; Fokt I; Szymanski S; Swierk P; Szeja W; Priebe W; Lesyng B; LaRonde-LeBlanc N
    Biochim Biophys Acta; 2013 Jul; 1834(7):1292-301. PubMed ID: 23523885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.
    Hines AC; Cole PA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2951-4. PubMed ID: 15125966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inhibitory effect of actin on casein kinase II activity in vitro.
    Karino A; Tanoue S; Fukuda M; Nakamura T; Ohtsuki K
    FEBS Lett; 1996 Dec; 398(2-3):317-21. PubMed ID: 8977130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine.
    Sharma V; Tepe JJ
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4319-21. PubMed ID: 15261294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
    Rudrabhatla P; Rajasekharan R
    Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
    Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
    EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative electrostatic analysis of adenylyl cyclase for isoform dependent regulation properties.
    Tong R; Wade RC; Bruce NJ
    Proteins; 2016 Dec; 84(12):1844-1858. PubMed ID: 27667304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition.
    Wilke KE; Fihn CA; Carlson EE
    Bioorg Med Chem; 2018 Oct; 26(19):5322-5326. PubMed ID: 29706527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol.
    Wang BH; Lu ZX; Polya GM
    Planta Med; 1998 Apr; 64(3):195-9. PubMed ID: 9581512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
    Murakami-Mori K; Mori S; Bonavida B; Nakamura S
    J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
    Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco by-2 cells].
    Sheremet IaA; Emets AI; Azmi A; Vissenberg K; Verbelen JP; Blium IaB
    Tsitol Genet; 2012; 46(2):3-11. PubMed ID: 22679818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
    Barnett SF; Defeo-Jones D; Fu S; Hancock PJ; Haskell KM; Jones RE; Kahana JA; Kral AM; Leander K; Lee LL; Malinowski J; McAvoy EM; Nahas DD; Robinson RG; Huber HE
    Biochem J; 2005 Jan; 385(Pt 2):399-408. PubMed ID: 15456405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of ligand binding to cAMP-dependent protein kinase.
    Hünenberger PH; Helms V; Narayana N; Taylor SS; McCammon JA
    Biochemistry; 1999 Feb; 38(8):2358-66. PubMed ID: 10029529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
    Seternes OM; Johansen B; Moens U
    Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.
    Lin WW; Chen BC
    Br J Pharmacol; 1998 Dec; 125(7):1601-9. PubMed ID: 9884090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.